Sumant Ramachandra
Vermögen: 173 300 $ am 31.05.2026
Vermögen: 173 300 $ am 31.05.2026
Derzeit ist Sumant Ramachandra Senior VP, Chief Science & Technology Officer bei Baxter International, Inc. Dr. Ramachandra ist auch Mitglied des Vorstands von Arog Pharmaceuticals, Inc. Dr. Ramachandra war zuvor Chief Scientific Officer & SVP-Regulatory Affairs bei Hospira, Inc., President-Research & Development bei Synta Pharmaceuticals Corp., Senior Vice President, Head-Research & Development bei Pfizer Essential Health und Vice President bei Schering-Plough Corp. Er erhielt einen Undergraduate-Abschluss von der Rutgers State University of New Jersey, einen Doktortitel von der University of Medicine & Dentistry of New Jersey und einen MBA von der Wharton School der University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC. 0,04 % | 10.06.2026 | 10 000 ( 0,04 % ) | 173 300 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.11.2024 |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Direktor/Vorstandsmitglied | - |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Vorstandsvorsitzender | 20.04.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Vorstandsvorsitzender | 31.10.2024 |
| BAXTER INTERNATIONAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2021 |
| HOSPIRA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 05.05.2013 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01.01.2008 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen